ICAM1 and prostate cancer: In the context of cancer, simvastatin mediates suppress prostate cancer PC3 micrometastasis through inhibition of integrin αvβ3 activity and suppression of the interaction between prostate cancer cell integrin αvβ3 and endothelial intercellular adhesion molecule (ICAM)-1 [13].